March 19, 2026 9:45am
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, announced that a comprehensive summary of clinical trials evaluating HyBryte(TM) (synthetic hypericin) for cutaneous T-cell lymphoma has been published in the peer-reviewed journal Expert Opinion on Investigational Drugs, highlighting the therapy’s safety profile, non-mutagenic mechanism and demonstrated efficacy across studies, while supporting its potential as a first-line treatment […]
March 19, 2026 9:33am
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, was featured in the latest BioMedWire Podcast episode where CEO Christopher Schaber discussed the upcoming interim analysis of the Phase 3 FLASH2 study evaluating HyBryte(TM) for cutaneous T-cell lymphoma, noting strong blinded aggregate response rates above initial assumptions and outlining potential outcomes including early study completion or continued enrollment, while […]
March 19, 2026 8:40am
Forward Industries (NASDAQ: FWDI), the leading Solana treasury company, announced it has entered into a privately negotiated agreement to repurchase 6,164,324 shares for $27.4 million, reducing shares outstanding and increasing SOL-per-share to 0.0662 following the transaction, which is being financed through a $40 million digital currency loan agreement with Galaxy Digital secured by treasury assets […]
March 19, 2026 8:00am
Datavault AI (NASDAQ: DVLT), a provider of data monetization, credentialing, digital engagement and real-world asset tokenization technologies, announced it has signed a definitive agreement to acquire NYIAX Inc., adding NYIAX’s intellectual property portfolio and blockchain-powered trading platform to support Datavault AI’s planned rollout of specialized exchanges, including its Information Data Exchange(R), while combining AI-driven valuation, […]
March 18, 2026 9:50am
Nutriband (NASDAQ: NTRB) announced that the Costa Rica Ministry of Health has approved its line of kinesiology tapes for import and sale, with exclusive distribution partner Innomedica CCB overseeing and financing the regulatory process. The company plans to ramp up marketing efforts in partnership with Innomedica, targeting both its kinesiology tape products and mosquito repellent patch line following the […]
March 18, 2026 9:30am
Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform redefining the path to homeownership, recently announced a collaboration with TYTL Corp., a company developing a blockchain-enabled system that tokenizes deed-recorded equity interests in residential real estate. Under the agreement, Beeline will support fractional equity acquisitions through its BeelineEquity platform while its subsidiary, Beeline Title, will […]
March 18, 2026 8:00am
Medical progress has transformed the treatment of many common illnesses, yet thousands of rare diseases still lack effective therapies. Companies working at the intersection of biotechnology innovation and rare disease research are increasingly focused on addressing these gaps, including Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company developing and commercializing therapies and vaccines for rare diseases […]
March 17, 2026 10:40am
NRx Pharmaceuticals (NASDAQ: NRXP) announced it received a letter from the FDA’s Bioequivalence Program stating no bioequivalence deficiencies were identified at this time in its Abbreviated New Drug Application, with a preliminary determination ahead of anticipated approval in Summer 2026. The company highlighted its preservative-free ketamine formulation, which excludes benzethonium chloride, as a potential advancement in safety and stability, while continuing to pursue […]
March 17, 2026 9:07am
Safe Pro Group (NASDAQ: SPAI) announced it has completed participation in the U.S. Army Transforming in Contact (TiC) 2.0 Autonomous Breach event, where its patented AI tools were deployed in real-world operational environments by soldiers and command personnel during a two-week exercise at Fort Hood, Texas. The company’s SPOTD platform and NODE system were used to identify threats, […]
March 17, 2026 8:00am
Safe Pro Group (NASDAQ: SPAI), a tech company that delivers security and defense solutions, recently announced that it has completed the full delivery of the company’s AI-powered edge processing systems valued at $1 million to the U.S. Government (https://ibn.fm/hNZEA). Safe Pro Group’s AI-powered edge processing systems are tactical, hardware-based units able to analyze drone imagery […]
March 17, 2026 8:00am
Datavault AI (NASDAQ: DVLT) announced it will report financial results for the fourth quarter and full year 2025 prior to market open on March 19, 2026, followed by a conference call and live webcast at 8:30 a.m. ET the same day. CEO Nathaniel Bradley and CFO Brett Moyer will host the presentation, with dial-in access […]
March 16, 2026 2:33pm
Innovation Beverage Group (NASDAQ: IBG) announced the closing of a registered public offering that generated approximately $6 million in gross proceeds before fees and expenses. The offering consisted of 3,428,569 common units or pre-funded units, each including one ordinary share or pre-funded warrant along with Series A and Series B warrants to purchase additional ordinary shares at an exercise price of $1.75 per share. […]
March 16, 2026 9:54am
Wearable Devices (NASDAQ: WLDS) announced a significant expansion of its AI expert advisory board to support the advancement of its ai6 Labs initiative, which is focused on neural AI innovation powered by non-invasive electromyography technology and the company’s Mudra platform. The company said the expanded advisory leadership includes Leor Stern as Senior AI Advisor for strategic growth alongside existing […]
March 16, 2026 8:45am
LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), a clinical-stage pharmaceutical company, and the company’s subsidiary, Liora Technologies, both develop cancer therapies that, when combined, have the potential to improve outcomes and results for cancer patients. LIXTE’s flagship product and lead clinical candidate is LB-100, which is a proprietary small-molecule inhibitor of protein phosphatase 2A (“PP2A”). Designed […]
March 16, 2026 8:25am
Rail Vision (NASDAQ: RVSN) announced the successful completion of a proof of concept demonstration of its AI-integrated MainLine railway safety system in India following a two-month evaluation conducted under real-world operating conditions with a major local rail operator in collaboration with Sujan Industries. The company said the trial assessed real-time object detection and classification, operational […]
March 16, 2026 8:10am
NRx Pharmaceuticals (NASDAQ: NRXP) announced that minutes from a Type C meeting with the U.S. Food and Drug Administration support the agency’s willingness to review a New Drug Application for NRX-100, a preservative-free ketamine formulation, based on existing clinical trial data demonstrating substantial evidence of effectiveness without requiring additional clinical trials. The company said the […]
March 16, 2026 8:00am
Pelican Acquisition (NASDAQ: PELI) is a publicly traded special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Pelican has entered into a proposed business combination with Greenland Exploration Limited and March GL Company that is expected to […]
March 13, 2026 12:53pm
USA Rare Earth (Nasdaq: USAR) and Texas Mineral Resources (OTCQB: TMRC) announced a definitive agreement under which USAR will acquire all outstanding shares of TMRC in exchange for 3,823,328 shares of USAR common stock in a transaction valued at approximately $73 million. The acquisition will consolidate USAR’s ownership of the Round Top Project in Texas, making the company […]